Evaluation of patient and encounter decision aid interventions for atrial fibrillation: Baseline characteristics of the RED-AF study - A Randomized Controlled Trial

被引:0
|
作者
Nayak, Tanvi [1 ]
Christensen, Joshua T. [2 ]
Bardsley, Tyler [2 ]
Barnes, Geoffrey D. [3 ]
Cameron, Kenzie A. [4 ]
Passman, Rod [5 ]
Kansal, Preeti [5 ]
Witt, Daniel M. [2 ,6 ]
Cavanaugh, Kerri L. [7 ]
Fagerlin, Angela [2 ]
Ozanne, Elissa M. [2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
[2] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84108 USA
[3] Univ Michigan, Dept Med, Div Cardiovasc Med, Ann Arbor, MI USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL USA
[5] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Evanston, IL USA
[6] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT USA
[7] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN USA
关键词
Atrial fibrillation; Shared decision-making; Decision aids; Clinical trial; Randomized controlled trial; STROKE; NUMERACY;
D O I
10.1016/j.cct.2024.107773
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation (RED-AF) trial is a multi-site, randomized controlled clinical trial examining the effectiveness of a patient decision aid and an encounter decision aid in promoting shared decision-making (SDM) during a clinical encounter for patients with atrial fibrillation (AF). We sought to describe baseline characteristics of patients and clinicians in the trial and compare them to the demographics of the larger AF population. We also conducted an analysis of possible predictors of attrition rates at baseline, 6 and 12 months. Methods: This study was a multi-center randomized controlled trial conducted at six academic centers across the U.S. Patients with non-valvular AF who qualify for anticoagulation therapy were eligible for enrollment. Patient demographics and characteristics were evaluated via questionnaires after their baseline clinical encounter. Participating clinicians completed demographic surveys, reporting educational background, specialty, and years of experience. Patient characteristics were analyzed via univariate logistic regression to identify potential trends among those lost to follow-up at each timepoint. Findings: A total of 1117 patients were enrolled in the RED-AF trial, with an average age of 69 (SD 9.3). Patients were predominantly male (61.7 %) and white (89.1 %), with 33.7 % reporting graduate or professional education. Clinicians (N = 107) were enrolled from specialties including cardiology (68.2 %), internal medicine (13.1 %), and pharmacy (14.0 %). No significant associations were found between any measured patient characteristics with survey completion at baseline, 6 or 12 months. Conclusion: The baseline demographics of the RED-AF trial reflect that patient participants were largely similar to prior studies investigating shared-decision making in patients with AF. The lack of association between patient demographics and attrition rates may highlight equity across the tested subgroups for survey completion for the study as a whole.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial)
    Kostick, Kristin M.
    Bruce, Courtenay R.
    Minard, Charles G.
    Volk, Roberti.
    Civitello, Andrew
    Krim, Selim R.
    Horstmanshof, Douglas
    Thohan, Vinay
    Loebe, Matthias
    Hanna, Mazen
    Bruckner, Brian A.
    Blumenthal-Barby, J. S.
    Estep, Jerry D.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (10) : 661 - 671
  • [42] Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial
    Singh, Jasvinder A.
    Shah, Nipam
    Green, Candace
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18 : 1 - 10
  • [43] Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial
    Jasvinder A. Singh
    Nipam Shah
    Candace Green
    BMC Musculoskeletal Disorders, 18
  • [44] Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2)
    Piazza, Gregory
    Hurwitz, Shelley
    Campia, Umberto
    Bikdeli, Behnood
    Lou, Junyang
    Khairani, Candrika D.
    Bejjani, Antoine
    Snyder, Julia E.
    Pfeferman, Mariana
    Barns, Briana
    Rizzo, Samantha
    Glezer, Alexandra
    Goldhaber, Samuel Z.
    THROMBOSIS RESEARCH, 2023, 227 : 1 - 7
  • [45] Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
    Nery, Pablo B.
    Wells, George A.
    Verma, Atul
    Joza, Jacqueline
    Nair, Girish M.
    Veenhuyzen, George
    Andrade, Jason
    Nault, Isabelle
    Wong, Jorge A.
    Sikkel, Markus
    Essebag, Vidal
    Macle, Laurent
    Sapp, John
    Roux, Jean-Francois
    Skanes, Allan
    Angaran, Paul
    Novak, Paul
    Redfearn, Damian
    Golian, Mehrdad
    Redpath, Calum J.
    Sturmer, Marcio
    Birnie, David
    AMERICAN HEART JOURNAL, 2022, 254 : 133 - 140
  • [46] Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial
    Masahito Jimbo
    Karen Kelly-Blake
    Ananda Sen
    Sarah T Hawley
    Mack T Ruffin
    Trials, 14
  • [47] Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial
    Jimbo, Masahito
    Kelly-Blake, Karen
    Sen, Ananda
    Hawley, Sarah T.
    Ruffin, Mack T.
    TRIALS, 2013, 14
  • [48] PAD TYPE AND MANUAL PRESSURE AUGMENTATION WITH MAXIMUM OUTPUT SHOCKS IN ATRIAL FIBRILLATION CARDIOVERSION: A RANDOMIZED CONTROLLED TRIAL (PRESS-AF STUDY)
    Lakananurak, Chanokphorn
    Cutting, Dina
    Lockwood, Evan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 79 - 79
  • [49] Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study
    Smith, Heather A.
    Kanji, Salmaan
    Tran, Diem T. T.
    Redpath, Calum
    Ferguson, Dean
    Lenet, Tori
    Sigler, Greg
    Gilbert, Sebastien
    Maziak, Donna
    Villeneuve, Patrick
    Sundaresan, Sudhir
    Seely, Andrew J. E.
    TRIALS, 2021, 22 (01)
  • [50] Evaluation of a decision aid for early pregnancy loss: A pilot randomized controlled trial in Philadelphia, Pennsylvania
    Flynn, Anne N.
    Mcallister, Arden
    Kete, Corinne
    Koelper, Nathanael C.
    Gallop, Robert J.
    Schreiber, Courtney A.
    Schapira, Marilyn M.
    Sonalkar, Sarita
    CONTRACEPTION, 2023, 125